Misfeldt Dayton

CIK 00014614662 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001461466

Recent Transactions

50 trades

Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2020-06-30+60,000→ 60,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2020-03-31+480,000→ 480,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2019-06-28+480,000→ 480,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2019-06-28+60,000→ 60,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2018-12-31+200,000→ 200,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option(Right to Buy)
2018-06-29+25,000→ 25,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2018-06-29+200,000→ 200,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2017-12-29+200,000→ 200,000 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock Warrants (right to buy)
2017-10-27+3,740→ 3,740 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2017-10-27$2.00/sh+392,520→ 1,598,260 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock Warrants (right to buy)
2017-10-27+196,260→ 196,260 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2017-10-27$2.00/sh+7,480→ 30,456 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2017-05-31+25,000→ 25,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2016-06-30+50,000→ 50,000 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2015-12-21$0.84/sh+1,717,275→ 7,234,441 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2015-12-21$0.84/sh+32,725→ 137,859 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2015-07-24$3.64/sh−3,962→ 105,134 total
Exercise of In-Money
Viracta Therapeutics, Inc.$VIRX
Warrant (right to buy)
2015-07-24+10,383→ 0 total
Exercise of In-Money
Viracta Therapeutics, Inc.$VIRX
Warrant (right to buy)
2015-07-24+20,766→ 0 total
Exercise of In-Money
Viracta Therapeutics, Inc.$VIRX
Common Stock
2015-07-24$1.32/sh+20,766→ 106,638 total
Exercise of In-Money
Viracta Therapeutics, Inc.$VIRX
Common Stock
2015-07-24$1.32/sh+544,893→ 5,725,104 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2015-07-24$3.46/sh−415,877→ 5,180,211 total
Exercise of In-Money
Viracta Therapeutics, Inc.$VIRX
Warrant (right to buy)
2015-07-24+544,893→ 0 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2015-07-24$3.46/sh−7,925→ 98,713 total
Exercise of In-Money
Viracta Therapeutics, Inc.$VIRX
Warrant (right to buy)
2015-07-24+1,089,788→ 0 total
Exercise of In-Money
Viracta Therapeutics, Inc.$VIRX
Common Stock
2015-07-24$1.32/sh+1,089,788→ 5,596,088 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2015-07-24$3.46/sh−207,938→ 5,517,166 total
Exercise of In-Money
Viracta Therapeutics, Inc.$VIRX
Common Stock
2015-07-24$1.32/sh+10,383→ 109,096 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2015-06-30+40,000→ 40,000 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2014-08-28$7.89/sh−196,260→ 4,506,300 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2014-08-28$7.89/sh−3,740→ 85,872 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2014-08-27$8.16/sh−98,817→ 4,702,560 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2014-08-27$8.16/sh−1,883→ 89,612 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2014-08-12$6.77/sh−36,406→ 4,801,377 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2014-08-12$6.77/sh−694→ 91,495 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2014-08-11$6.90/sh−591→ 92,189 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2014-08-11$6.90/sh−31,009→ 4,837,783 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2014-08-08$6.62/sh−12,622→ 92,780 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stock
2014-08-08$6.62/sh−662,378→ 4,868,792 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2014-06-30+20,000→ 20,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2013-06-28+20,000→ 20,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2012-06-29+25,000→ 25,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2011-06-30+50,000→ 50,000 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2010-06-30−980,809→ 0 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30$0.28/sh+23,378,934→ 23,378,934 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2010-06-30−18,690→ 0 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30$0.28/sh+445,516→ 445,516 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30+186,900→ 632,416 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30+9,808,090→ 33,187,024 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2010-06-02+10,000→ 10,000 total

Companies

Recent Filings

Address

C/O BAY CITY CAPITAL LLC 750 BATTERY STREET, SUITE 400

SAN FRANCISCO, CA, 94111

View on SEC.gov